DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching... Show more
The Stochastic Oscillator for DRIO moved out of overbought territory on January 09, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 53 similar instances where the indicator exited the overbought zone. In of the 53 cases the stock moved lower. This puts the odds of a downward move at .
DRIO moved below its 50-day moving average on January 09, 2026 date and that indicates a change from an upward trend to a downward trend.
The 50-day moving average for DRIO moved below the 200-day moving average on December 29, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DRIO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for DRIO entered a downward trend on December 31, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Momentum Indicator moved above the 0 level on January 06, 2026. You may want to consider a long position or call options on DRIO as a result. In of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for DRIO just turned positive on January 05, 2026. Looking at past instances where DRIO's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DRIO advanced for three days, in of 255 cases, the price rose further within the following month. The odds of a continued upward trend are .
DRIO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.061) is normal, around the industry mean (21.885). P/E Ratio (0.000) is within average values for comparable stocks, (109.191). DRIO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.461). Dividend Yield (0.000) settles around the average of (0.029) among similar stocks. P/S Ratio (1.422) is also within normal values, averaging (66.451).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. DRIO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DRIO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.
a developer of technology to address the diabetic self-monitoring of blood glucose
Industry ServicestotheHealthIndustry
A.I.dvisor indicates that over the last year, DRIO has been loosely correlated with TWST. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if DRIO jumps, then TWST could also see price increases.
| Ticker / NAME | Correlation To DRIO | 1D Price Change % | ||
|---|---|---|---|---|
| DRIO | 100% | +0.77% | ||
| TWST - DRIO | 34% Loosely correlated | +5.73% | ||
| VCYT - DRIO | 28% Poorly correlated | -0.92% | ||
| XWEL - DRIO | 28% Poorly correlated | -2.59% | ||
| BNGO - DRIO | 28% Poorly correlated | -0.63% | ||
| ILMN - DRIO | 27% Poorly correlated | +0.99% | ||
More | ||||
| Ticker / NAME | Correlation To DRIO | 1D Price Change % |
|---|---|---|
| DRIO | 100% | +0.77% |
| Services to the Health Industry industry (92 stocks) | 2% Poorly correlated | -0.34% |
| Health Services industry (412 stocks) | 2% Poorly correlated | -0.23% |